Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

7Seas cancer claims attract FDA attention

This article was originally published in The Tan Sheet

Executive Summary

Supplement claims made by 7Seas LLC on Web sites such as 1www.AlternateCancerCure.com and 2www.TreatAllCancer.com elicit an April 5 warning letter from FDA's Florida District office. The letter to Norman Hem of the Hialeah, Fla.-based firm alleges that products, including Jade Windscreen, Apricot Seeds and Miracle Mineral Supplement, make disease claims causing them to be unapproved drugs. According to the agency, 7Seas' claims include, "The most powerful, PROVEN cancer treatment and prevention products EVER known to humankind" and "MMS is the answer to ... malaria, hepatitis A, B and C, colds, herpes, TB, most cancer, flu, pneumonia, as well as many other illnesses and diseases." The firm had 15 days to respond to FDA

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS104030

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel